MYN

Mainz Biomed

Stock
Stock
ISIN: NL0015000LC2
Ticker: MYNZ
NL0015000LC2
MYNZ

Price

Price

CHART BY

Frequently asked questions

What is Mainz Biomed's market capitalization?

The market capitalization of Mainz Biomed is $5.53M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Mainz Biomed?

Mainz Biomed's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$65.57. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Mainz Biomed's stock?

Currently, 1 analysts cover Mainz Biomed's stock, with a consensus target price of $14.00. Analyst ratings provide insights into the stock's expected performance.

What is Mainz Biomed's revenue over the trailing twelve months?

Over the trailing twelve months, Mainz Biomed reported a revenue of $895.48K.

What is the EBITDA for Mainz Biomed?

Mainz Biomed's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$25.48M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Mainz Biomed?

Mainz Biomed has a free cash flow of -$23.14M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Mainz Biomed have, and what sector and industry does it belong to?

Mainz Biomed employs approximately 26 people. It operates in the Health Care sector, specifically within the Biotechnology industry.

What is the free float of Mainz Biomed's shares?

The free float of Mainz Biomed is 3.69M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$5.53M
EPS (TTM) 
-$65.57
Free Float 
3.69M
Revenue (TTM) 
$895.48K
EBITDA (TTM) 
-$25.48M
Free Cashflow (TTM) 
-$23.14M

Pricing

52W span
$1.34$20.00

Analyst Ratings

The price target is $14.00 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.

Employees
26
Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
NL0015000LC2
Primary Ticker
MYNZ
Fundamentals & EOD data from FactSet
Join the conversation